Real-World Dose Adjustment and Switching of Interleukin-17/23 Inhibitors for Thai Psoriasis
Interleukin (IL)-17 and IL-23 inhibitors have transformed psoriasis care, delivering high clearance rates and quality-of-life gains. Nevertheless, inadequate response or adverse events can lead to treatment discontinuation or biologic switching. Dose modifications are also commonly implemented in ro...
Збережено в:
| Автори: | , , , , , , |
|---|---|
| Формат: | Artigo |
| Мова: | Inglês |
| Опубліковано: |
Wiley
2026-01-01
|
| Серія: | Dermatology Research and Practice |
| Онлайн доступ: | http://dx.doi.org/10.1155/drp/7998583 |
| Теги: |
Немає тегів, Будьте першим, хто поставить тег для цього запису!
|